Nodality, Inc., UCB Pharma (UCBJF.PK) Strike Multi-Year Companion Diagnostic Pact
2/10/2012 8:53:47 AM
More...
|
ALS Therapy Development Institute Announces Research Agreement with Biogen Idec, Inc. (Massachusetts) (BIIB) and UCB Pharma (UCBJF.PK) to Investigate the Role of CD40L in ALS
12/19/2011 10:38:14 AM
More...
|
UCB Pharma (UCBJF.PK) To Test Arthritis Drug Cimzia Against Abbott Laboratories (ABT)'s Humira
5/26/2011 6:52:02 AM
More...
|
UCB Pharma (UCBJF.PK) and PDL BioPharma, Inc. (PDLI) Resolve Patent Disputes; UCB to Pay PDL $10 Million
2/8/2011 7:09:58 AM
More...
|
Transdermal Rotigotine Improves Quality of Life in Patients with Parkinson's Disease: Presented at WPC, UCB Pharma (UCBJF.PK) Study
10/6/2010 12:21:09 PM
More...
|
Inaugural BIOTECanada-UCB Pharma (UCBJF.PK) National Health Innovation Patient Advocacy Awards Granted
9/25/2008 9:39:29 AM
More...
|
Entelos, Inc. Enters Research Deal with UCB Pharma (UCBJF.PK) in Rheumatoid Arthritis
1/21/2008 8:05:36 AM
More...
|
Mylan Laboratories Inc. (MYL) Settles Its First-to-File Opportunity on Levetiracetam with UCB Pharma (UCBJF.PK)
10/5/2007 9:46:18 AM
More...
|
UCB Group (UCBJF.PK) And Sanofi-Aventis (France) (SASY.PA) Sign A Co-Promotion Agreement For Xyzal(R); In The United States
9/25/2006 4:44:18 PM
More...
|
Crucell N.V. (CRXL) And UCB Group (UCBJF.PK) Sign STAR(TM) License Agreement
9/7/2006 4:15:58 PM
More...
|
|